Amy B. Summy - 11 Feb 2022 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role
EVP, Chief Marketing Officer
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Amy B. Summy
Issuer symbol
LH
Transactions as of
11 Feb 2022
Net transactions value
$0
Form type
4
Filing time
15 Feb 2022, 12:46:10 UTC
Previous filing
08 Feb 2022
Next filing
14 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Restricted Stock Unit Award $0 +540 +26% $0.000000 2,587 11 Feb 2022 Common Stock 540 Direct F1, F2, F3
transaction LH Non-qualified Stock Options Award $0 +1,900 $0.000000 1,900 11 Feb 2022 Common Stock 1,900 $276.26 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2 The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2023.
F3 This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
F4 Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
F5 The option vests in three equal annual installments beginning on the date reflected in this column.